LIVER
Antagonist
Antagonist
Julia Skellie · 178問 · 2年前Antagonist
Antagonist
178問 • 2年前Monitors
Monitors
Julia Skellie · 144問 · 2年前Monitors
Monitors
144問 • 2年前Positioning
Positioning
Julia Skellie · 88問 · 2年前Positioning
Positioning
88問 • 2年前arterial vasodilators, peripheral vasodilators, CCB
arterial vasodilators, peripheral vasodilators, CCB
Julia Skellie · 122問 · 2年前arterial vasodilators, peripheral vasodilators, CCB
arterial vasodilators, peripheral vasodilators, CCB
122問 • 2年前AntiArrhythmics
AntiArrhythmics
Julia Skellie · 70問 · 2年前AntiArrhythmics
AntiArrhythmics
70問 • 2年前just dont forget:
just dont forget:
Julia Skellie · 8問 · 2年前just dont forget:
just dont forget:
8問 • 2年前Rspiratory
Rspiratory
Julia Skellie · 42問 · 2年前Rspiratory
Rspiratory
42問 • 2年前Monitored and Conscious Sedation
Monitored and Conscious Sedation
Julia Skellie · 48問 · 2年前Monitored and Conscious Sedation
Monitored and Conscious Sedation
48問 • 2年前Emergence
Emergence
Julia Skellie · 29問 · 2年前Emergence
Emergence
29問 • 2年前PACU
PACU
Julia Skellie · 14問 · 2年前PACU
PACU
14問 • 2年前Random
Random
Julia Skellie · 19問 · 2年前Random
Random
19問 • 2年前pharm exam 3
pharm exam 3
Julia Skellie · 42問 · 2年前pharm exam 3
pharm exam 3
42問 • 2年前Pharm Induction Agents
Pharm Induction Agents
Julia Skellie · 58問 · 2年前Pharm Induction Agents
Pharm Induction Agents
58問 • 2年前Laparoscopic Surgery
Laparoscopic Surgery
Julia Skellie · 39問 · 2年前Laparoscopic Surgery
Laparoscopic Surgery
39問 • 2年前Hematology Coagulation
Hematology Coagulation
Julia Skellie · 66問 · 2年前Hematology Coagulation
Hematology Coagulation
66問 • 2年前ENT
ENT
Julia Skellie · 17問 · 2年前ENT
ENT
17問 • 2年前Opioids
Opioids
Julia Skellie · 18問 · 2年前Opioids
Opioids
18問 • 2年前MH
MH
Julia Skellie · 32問 · 2年前MH
MH
32問 • 2年前NeuroSurg
NeuroSurg
Julia Skellie · 20問 · 2年前NeuroSurg
NeuroSurg
20問 • 2年前Burns
Burns
Julia Skellie · 89問 · 2年前Burns
Burns
89問 • 2年前Regional
Regional
Julia Skellie · 11問 · 2年前Regional
Regional
11問 • 2年前問題一覧
1
7-11 rib right midaxillary line T3-T11 largest organ RUQ blood reservoir
2
lobule 50-100K hexagonal in corsssection with center central vein and 6 portal veins hepatocytes circumference the central vein
3
connective tissue covering liver and parts of H arty, P vein and bile ducts
4
remove bacteria before blood drains into IVC
5
gall bladder canaliculi common hepatic duct duodenum sphincter of oddi
6
disse
7
30%
8
aorta > splancnic organs > portal vein > liver
9
75%
10
50 and lower than hepatic artery
11
A1 vasocon D1 vasodilation
12
normal 7-10mmHG pHTN 20-20mmHg
13
aorta > hepatic arty > liver
14
25
15
50% and higher
16
A1 vasocon B2 D1 vasodilation
17
when portal vein decreases flow the hepatic artery compensates by increasing flow by washing out vasodilators (adenosine)
18
hypoxia, pain, SNS activation> increase in splanchnic vascular resistance hemorrhage > blood diverts elsewhere anesthesia > decrease MAP PPV, increase volume, CHF> increase CVP
19
procoagulants: all clotting facotrs (except for 8) anticoag: antithrombin, protein C, S, Z fibrinolytics: plasminogen thrombopoetin: stimulates plt production
20
carbs: regulate glucose, clears insulin liver failur: hypoglycemia
21
AA deamination: proteins> carbs/fats produces ammonia > urea hepatic encephalopathy albumin
22
triglycerides = energy storage synthesis of: cholesterol phospholipids lipoproteins
23
aged RBC >> unconj bilir in spleen >> liver conjugation with glucagon in acid > conj bilir excreted in bile
24
1. req for fat and fat soluble vitamin absorption 2. excretion pathway for bilirubin and metabolic products 3. alkalication of duodenum
25
hemolysis > unconj bilir > neurotoxic and jaundice
26
increase = perfusion depended clearance
27
portal HTN varicies ascites
28
splenomegaly; plt sequestration; thrombocytopenia
29
loss of hemostasis decrease: clotting factors, plts anemia: increase bleeding, increase RBC destruction, nutritional def
30
bio transformation impaired decrease amount and quality of albumin > ascites, edem, altered drug kinetics increase protein bound drugs will have high VOD
31
Tylenol- consumes livers glutathione NSAIDS ETOH- no fatty acid metabolism and hepatmegly toxins halothene
32
liver inflammation hepatocellura injury with vary necrosis degree most common cause of liver cancer and trampsoant
33
ETOH hep 3
34
recurrent exacerbation of acute inflammation rarely get to cirrhosis
35
progressive heptoctye destruction and cirrhosis clinical: mult organ failure, enceph, variceis rupture sx: jaundice, fatigue, throbotyov, neuropathy, myocarditis, PT prolong, arthritis, glomnephritis, low albumin
36
+ammonia +ICP> somnolence and encephalahty impaired BBB> coma neuro transmission alteration > increase uptake of benzos
37
HYPOXEMIA from anemia and low blood viscosity HYPOVOLEMIA from decrease PRV and increase CO
38
CO cats
39
nodules and fibrotic tissue increase sinusoids portal HTN collateral vessels >> portostytemic shunt EXTENSIVE DISORGANIZATION OF LOBULAR STRUCTURE MULTISYSTEM ORGAN FAILURE
40
reduces esophageal sphincter tone > aspiration > RSI malnutrition bowel edem, less drug bound and more free drug GI bleed jaundice ascites and dilutional hyponatremia
41
hypoxemia, R to L shunt, VQ mismatch decrease oxygen affinity for hgb shifts R decrease FRC, compliance > atelectasis hyperventilation impairs HPV
42
increase RAAS > increase aldosterone and water retention > hypokalemia, dilutional hyponatremia dilutional hyponatremia relative hypovolemia and ascites cirrhosis + portal htn + ascites = intense renal vasoconstriction; decrease RBF decrease UO with almost no Na+ increase BUN/Cr
43
volume oxygen: VQ mismatch and ascites electrolytes heme
44
ISO - not halothane avoid PEEP normocapnia liberal IVF regional OK if coags ok
45
Tylenol halothene amio penicillin and tetracycline
46
avoid: splanchnic resistance, light anesthesia , hypoxia, hypercarbia full. stomach, RSI maintain HBF and oxygenation
47
avoid: high concentration, high flow sevo, halothene, N2O bc of bowel distention and alters splanchnic flow
48
reduces polypharm requirement avoid low BP coags okay? decreases AMIDE local anesthesia metabolism so use ESTERS
49
small incremental dose impaired metabolism: protein binding high VOD hepatic ext ratios
50
reduced biliy excretion: roc risk succ and less pseudo NDNMB may require large initial dose less skeletal mass then less maintence does required good: cis, atricurium
51
maintain UO crystalloids albumin 25% blood, FFP, cryo, plt, vit K
52
hypercarbia>> SNS stimuli of splanchnic casvulature and decrease portal hepatic blood flow increase intrthorcic pressure with decreation HBF
53
onset: 6-8 hours after blood is normal peak: 24-36 hours early signs: tremor, disorientation late: increase SNS, NV, insomnia, agitation tx: alcohol, BB, A2 agonist 2-4 days signs: DTs, seizure, tachy, up or down BP, combative tx: diazepam, BB other tx: vit B (thiamine) and disulfiramin (hepatotoxic)
54
onset: 6-8 hours after blood is normal peak: 24-36 hours early signs: tremor, disorientation late: increase SNS, NV, insomnia, agitation tx: alcohol, BB, A2 agonist 2-4 days signs: DTs, seizure, tachy, up or down BP, combative tx: diazepam, BB other tx: vit B (thiamine) and disulfiramin (hepatotoxic)
55
onset: 6-8 hours after blood is normal peak: 24-36 hours early signs: tremor, disorientation late: increase SNS, NV, insomnia, agitation tx: alcohol, BB, A2 agonist 2-4 days signs: DTs, seizure, tachy, up or down BP, combative tx: diazepam, BB other tx: vit B (thiamine) and disulfiramin (hepatotoxic)
56
less
57
more MAC req
58
potentials GABA so increase effect of benzos inhibit NMDA receptor impaires pharyngeal reflex > aspiration
59
PT: 12-14 sec albumin: 2.5-5 bilirubin: 0-11 also: AST/ALT: 10-40 CBC, plt
60
hep C then ETOH
61
blood bank coagupathy for lining if encephalitic then no anti anxiety med do not correct hyponatremia too fast- central pontine
62
predict 90 day mortality facotrs: bilirubin, INR, creatinine
63
facors: albumin pt bilirubin ascites encephalotphy
64
preanaheptic
65
incision to cross clamp of portal vein, hepatic artery, IVC RSI CV instability massive transfusion CVP normal then increase to 10 right before clamping careful not give too much fluid to cause dilutional coagulapathy prevent hypothermia
66
hgb 7 plt 40 fib 100 TEG 45
67
removal of native liver to implantation of donor 3 methods: biocaval clamp piggy back venovenous bypass vascular clamping with cause decrease preload and CO (lowest here) no liver function worse coagulpahty, blood loss, lactic acidosis, hypoglycemia
68
reperfusion to biliary anastomosis complications: HYPERKALEMIA hypocal cytokine relae Lacie acid embolism debri hypothermia pulmHTN avoid high CVP
69
normal glucose normothermia acid base balance
70
neohepatic phase hypotension for at least 1 min for first 5 min of reperfusion (under 30% baseline) pressers, correct electrolytes, acid base
71
hemodynamic instability lack of bile output
72
poor graft: hemodynamic instability and lack of bile output no epidruel pain PCA anti rejection med- infection risk steroids might req insulin gtt
73
preop liver function 75 1. control of vessels 2. parenchymal transection 3. Pringle maneuver- 60-90 min max clamp
74
large resection or tumor in IVC entire area of IVC is clamped risk tearing IVC, VAE
75
vol and CV stability blood loss VAE extubate ?
76
transjugular intrahepatic portosystemic shunt temporary tx for hepatorenal syndrome bypass portion of hepatic circulation by shunting blood from port vein to hepatic vein will decrease portal pressure, less bleed from esophageal varies, and less ascites risk: hemorrhage
77
stimulates GB to contract
78
obesity increase age rapid wt loss prego women>men
79
leukoytosis fever RUQ pain muphys sign: worst with inspiration
80
GB distention edema perf risk jaundice
81
cholesystis jaundice pancreatitis peritonitis
82
gallstone in commonheptic duct and ERCP
83
stones in gall bladder and cholecystectomy
84
laposcopic avoid N2O if liver dysfunction use cisatricurium avoid opioids bc sphincter of oddi relax sphincter: glucagon, NGT, atropine